These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23200958)

  • 21. A non-covalent strategy combining cationic lipids and CPPs to enhance the delivery of splice correcting oligonucleotides.
    Trabulo S; Resina S; Simões S; Lebleu B; Pedroso de Lima MC
    J Control Release; 2010 Jul; 145(2):149-58. PubMed ID: 20362021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-penetrating peptides-based strategies for the delivery of splice redirecting antisense oligonucleotides.
    El Andaloussi S; Said Hassane F; Boisguerin P; Sillard R; Langel U; Lebleu B
    Methods Mol Biol; 2011; 764():75-89. PubMed ID: 21748634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insights into the cellular trafficking of splice redirecting oligonucleotides complexed with chemically modified cell-penetrating peptides.
    Hassane FS; Abes R; El Andaloussi S; Lehto T; Sillard R; Langel U; Lebleu B
    J Control Release; 2011 Jul; 153(2):163-72. PubMed ID: 21536086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of endocytosis in the uptake and intracellular trafficking of PepFect14-nucleic acid nanocomplexes via class A scavenger receptors.
    Juks C; Padari K; Margus H; Kriiska A; Etverk I; Arukuusk P; Koppel K; Ezzat K; Langel Ü; Pooga M
    Biochim Biophys Acta; 2015 Dec; 1848(12):3205-16. PubMed ID: 26409186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of splice correction by cell-penetrating peptide nucleic acids.
    El-Andaloussi S; Johansson HJ; Lundberg P; Langel U
    J Gene Med; 2006 Oct; 8(10):1262-73. PubMed ID: 16900561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SCARA Involvement in the Uptake of Nanoparticles Formed by Cell-Penetrating Peptides.
    Helmfors H; Lindberg S; Langel Ü
    Methods Mol Biol; 2015; 1324():163-74. PubMed ID: 26202269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors determining the efficacy of nuclear delivery of antisense oligonucleotides by gold nanoparticles.
    Liu Y; Franzen S
    Bioconjug Chem; 2008 May; 19(5):1009-16. PubMed ID: 18393455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A stearylated CPP for delivery of splice correcting oligonucleotides using a non-covalent co-incubation strategy.
    Mäe M; El Andaloussi S; Lundin P; Oskolkov N; Johansson HJ; Guterstam P; Langel U
    J Control Release; 2009 Mar; 134(3):221-7. PubMed ID: 19105971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nanoparticles-cell-penetrating peptide.
    Dowaidar M; Nasser Abdelhamid H; Hällbrink M; Langel Ü; Zou X
    J Biomater Appl; 2018 Sep; 33(3):392-401. PubMed ID: 30223733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PepFect14 Signaling and Transfection.
    Falato L; Gestin M; Langel Ü
    Methods Mol Biol; 2022; 2383():229-246. PubMed ID: 34766293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effective capture of proteins inside living cells by antibodies indirectly linked to a novel cell-penetrating polymer-modified protein A derivative.
    Itakura S; Hama S; Ikeda H; Mitsuhashi N; Majima E; Kogure K
    FEBS J; 2015 Jan; 282(1):142-52. PubMed ID: 25315678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delivery of therapeutic oligonucleotides with cell penetrating peptides.
    Boisguérin P; Deshayes S; Gait MJ; O'Donovan L; Godfrey C; Betts CA; Wood MJ; Lebleu B
    Adv Drug Deliv Rev; 2015 Jun; 87():52-67. PubMed ID: 25747758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PEG shielded MMP sensitive CPPs for efficient and tumor specific gene delivery in vivo.
    Veiman KL; Künnapuu K; Lehto T; Kiisholts K; Pärn K; Langel Ü; Kurrikoff K
    J Control Release; 2015 Jul; 209():238-47. PubMed ID: 25935707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Graphene oxide nanosheets in complex with cell penetrating peptides for oligonucleotides delivery.
    Dowaidar M; Abdelhamid HN; Hällbrink M; Zou X; Langel Ü
    Biochim Biophys Acta Gen Subj; 2017 Sep; 1861(9):2334-2341. PubMed ID: 28689990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delivery of nucleic acids with a stearylated (RxR)4 peptide using a non-covalent co-incubation strategy.
    Lehto T; Abes R; Oskolkov N; Suhorutsenko J; Copolovici DM; Mäger I; Viola JR; Simonson OE; Ezzat K; Guterstam P; Eriste E; Smith CI; Lebleu B; Samir El Andaloussi ; Langel U
    J Control Release; 2010 Jan; 141(1):42-51. PubMed ID: 19744531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular delivery of siRNA and antisense oligonucleotides via receptor-mediated endocytosis.
    Ming X
    Expert Opin Drug Deliv; 2011 Apr; 8(4):435-49. PubMed ID: 21381985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved cellular uptake of antisense peptide nucleic acids by conjugation to a cell-penetrating peptide and a lipid domain.
    Shiraishi T; Nielsen PE
    Methods Mol Biol; 2011; 751():209-21. PubMed ID: 21674333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knockdown of a G protein-coupled receptor through efficient peptide-mediated siRNA delivery.
    Hoyer J; Neundorf I
    J Control Release; 2012 Aug; 161(3):826-34. PubMed ID: 22626516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptide-based vectors: recent developments.
    Cerrato CP; Lehto T; Langel Ü
    Biomol Concepts; 2014 Dec; 5(6):479-88. PubMed ID: 25429600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of endosomolytic reagents by branching of cell-penetrating peptides: tools for the delivery of bioactive compounds to live cells in cis or trans.
    Angeles-Boza AM; Erazo-Oliveras A; Lee YJ; Pellois JP
    Bioconjug Chem; 2010 Dec; 21(12):2164-7. PubMed ID: 21043514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.